2009
DOI: 10.7812/tpp/08-069
|View full text |Cite
|
Sign up to set email alerts
|

Acute Phosphate Nephropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…5,20,21 The panel does not recommend the stool softener docusate as a primary treatment for CIC given that it was shown to be inferior to psyllium at improving stool frequency in a randomised controlled trial involving 170 patients with CIC. 22 Patients require adequate counselling on regular, consistent use of medications, regardless of clinical status after dose titration, to prevent the development of severe refractory symptoms.…”
Section: Statement 8: Pharmacological Management Should Be Consideredmentioning
confidence: 99%
“…5,20,21 The panel does not recommend the stool softener docusate as a primary treatment for CIC given that it was shown to be inferior to psyllium at improving stool frequency in a randomised controlled trial involving 170 patients with CIC. 22 Patients require adequate counselling on regular, consistent use of medications, regardless of clinical status after dose titration, to prevent the development of severe refractory symptoms.…”
Section: Statement 8: Pharmacological Management Should Be Consideredmentioning
confidence: 99%